Skip to main content

The UC Cancer Consortium Molecular Tumor Board (UCCC MTB) brings together precision oncology experts from across the UC system to discuss available biomarker-driven therapies for individual patients, ensuring systemwide awareness of the latest cutting-edge treatment options in cancer care.

Virtual Meetings

UCCC MTB 2023-2024 meetings occur bi-monthly, and participation is limited to UC affiliates with valid UC email addresses. For more information, contact the UC Cancer Consortium at

UCCC Molecular Tumor Board Virtual Meeting
May 14, 2024 at 8am PT
Register here.

Future meeting dates
Check back for more information!

Submit a case

Referring physicians from UC academic health centers may submit active patient cases in advance of MTB meetings. To submit a case, please:

1. Download and complete a case summary form.

2. Upload the completed case summary form and relevant genomics report to the UCCC MTB Secure Box Folder.

Improving the lives of cancer patients with the most difficult cases

We engage providers and experts from across the UC system to make the best possible clinical care recommendations not only for each disease type, but for each individual patient.

The UCCC MTB is jointly led by representatives from all UC academic health centers. Contact the UC Cancer Consortium at for more information.